| Name | UBP 301,(αS)-α-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinepropanoicacid |
|---|---|
| Synonyms |
UBP-301,UBP301
1(2H)-Pyrimidinropanoic acid, α-amino-3-[(4-cboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-, (αS) ubp 301 (alphaS)-alpha-Amino-3-[(4-cboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinropanoic acid (αS)-α-Amino-3-[(4-cboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinropanoicacid (AS)-ALPHA-AMINO-3-[(4-CBOXYPHENYL)METHYL]-3,4-DIHYDRO-5-IODO-2,4-DIOXO-1(2H)-PYRIMIDINROPANOIC ACID (aS)-a-Amino-3-((4-cboxyphenyl)methyl)-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinropanoicacid |
| Description | UBP301 is a potent and selective antagonist of kainate receptor with IC50 and KD of 164 μM and 5.94 μM, respectively. UBP301 has ∼30-fold selectivity of kainate receptor over AMPA receptor. UBP301 is the derivative of willardiine[1]. |
|---|---|
| Related Catalog | |
| Target |
164 μM (kainate receptor)[1] |
| References |
| Molecular Formula | C15H14IN3O6 |
|---|---|
| Molecular Weight | 459.19300 |
| Exact Mass | 458.99300 |
| PSA | 144.62000 |
| LogP | 0.47330 |